Pacer Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,043
| Closed | -$42.6K | – | 2697 |
|
|
2024
Q2 | $42.6K | Buy |
1,043
+8
| +0.8% | +$327 | ﹤0.01% | 3227 |
|
|
2024
Q1 | $43.7K | Buy |
+1,035
| New | +$43.7K | ﹤0.01% | 3222 |
|
|
2021
Q2 | – | Sell |
-1,444
| Closed | -$20K | – | 1576 |
|
|
2021
Q1 | $20K | Buy |
+1,444
| New | +$20K | ﹤0.01% | 1506 |
|